Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
Open Access
- 1 January 2013
- journal article
- Published by Springer Nature in Molecular Autism
- Vol. 4 (1) , 15
Abstract
Fragile X syndrome (FXS) is a common inherited form of intellectual disability caused by loss of function of the fragile X mental retardation protein. Recent animal studies suggest that upregulated downstream signaling by metabotropic glutamate receptor 5 (mGluR5) might be an important mechanism for cognitive and behavioral abnormalities associated with FXS. However, mGluR5 density in human FXS remains unknown.Keywords
This publication has 23 references indexed in Scilit:
- Fragile X-associated disorders: a clinical overviewJournal of Neurology, 2011
- Dysregulation of fragile × mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain studyMolecular Autism, 2011
- Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patientsThe EMBO Journal, 2010
- A pilot open label, single dose trial of fenobam in adults with fragile X syndromeJournal of Medical Genetics, 2009
- Metabotropic Glutamate Subtype 5 Receptors Are Quantified in the Human Brain with a Novel Radioligand for PETJournal of Nuclear Medicine, 2008
- In vitro receptor binding assays: general methods and considerations.2008
- Correction of Fragile X Syndrome in MiceNeuron, 2007
- A Reduced Number of Metabotropic Glutamate Subtype 5 Receptors Are Associated with Constitutive Homer Proteins in a Mouse Model of Fragile X SyndromeJournal of Neuroscience, 2005
- The fragile X mental retardation protein inhibits translation via interacting with mRNANucleic Acids Research, 2001
- Absence of expression of the FMR-1 gene in fragile X syndromeCell, 1991